Pre-eclampsia is a valuable opportunity to diagnose chronic kidney disease: a multicentre study.
chronic kidney disease
pre-eclampsia
pregnancy
preterm delivery
proteinuria
Journal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402
Informations de publication
Date de publication:
26 07 2022
26 07 2022
Historique:
received:
15
03
2021
pubmed:
3
8
2021
medline:
29
7
2022
entrez:
2
8
2021
Statut:
ppublish
Résumé
Pre-eclampsia (PE) and chronic kidney disease (CKD) are known to be associated. Our objective was to assess the prevalence of CKD in a large multicentre cohort of women without acknowledged CKD who experienced a PE episode. The setting for the study was France (Le Mans, Central France) and Italy (Cagliari, Sardinia). The study participants were patients who experienced PE in 2018-19, identified from the obstetric charts. Patients with known-acknowledged CKD were excluded. Only singletons were considered. Persistent (micro)albuminuria was defined as present and confirmed at least 3 months after delivery. CKD was defined according to the Kidney Disease Outcomes Quality Initiative guidelines; urinary alterations or low eGFR confirmed at a distance of at least 3 months, or morphologic changes. Patients were divided into four groups: evidence of CKD; no evidence of CKD; unclear diagnosis-ongoing work-up; or persistent microalbuminuria. The outcome 'diagnosis of CKD' was analysed by simple and multiple logistic regressions. Temporal series (week of delivery) were analysed with Kaplan-Meier curves and Cox analysis. Two hundred and eighty-two PE pregnancies were analysed (Le Mans: 162; Cagliari: 120). The incidence of CKD diagnosis was identical (Le Mans: 19.1%; Cagliari: 19.2%); no significant difference was found in unclear-ongoing diagnosis (6.2%; 5.8%) and microalbuminuria (10.5%; 5.8%). Glomerulonephritis and diabetic nephropathy were more frequent in Cagliari (higher age and diabetes prevalence), and interstitial diseases in Le Mans. In the multivariate logistic regression, CKD diagnosis was associated with preterm delivery (adjusted P = 0.035). Gestation was 1 week shorter in patients diagnosed with CKD (Kaplan-Meier P = 0.007). In Cox analysis, CKD remained associated with shorter gestation after adjustment for age and parity. The prevalence of newly diagnosed CKD is high after PE (19% versus expected 3% in women of childbearing age), supporting a systematic nephrology work-up after PE.
Sections du résumé
BACKGROUND
Pre-eclampsia (PE) and chronic kidney disease (CKD) are known to be associated. Our objective was to assess the prevalence of CKD in a large multicentre cohort of women without acknowledged CKD who experienced a PE episode.
METHODS
The setting for the study was France (Le Mans, Central France) and Italy (Cagliari, Sardinia). The study participants were patients who experienced PE in 2018-19, identified from the obstetric charts. Patients with known-acknowledged CKD were excluded. Only singletons were considered. Persistent (micro)albuminuria was defined as present and confirmed at least 3 months after delivery. CKD was defined according to the Kidney Disease Outcomes Quality Initiative guidelines; urinary alterations or low eGFR confirmed at a distance of at least 3 months, or morphologic changes. Patients were divided into four groups: evidence of CKD; no evidence of CKD; unclear diagnosis-ongoing work-up; or persistent microalbuminuria. The outcome 'diagnosis of CKD' was analysed by simple and multiple logistic regressions. Temporal series (week of delivery) were analysed with Kaplan-Meier curves and Cox analysis.
RESULTS
Two hundred and eighty-two PE pregnancies were analysed (Le Mans: 162; Cagliari: 120). The incidence of CKD diagnosis was identical (Le Mans: 19.1%; Cagliari: 19.2%); no significant difference was found in unclear-ongoing diagnosis (6.2%; 5.8%) and microalbuminuria (10.5%; 5.8%). Glomerulonephritis and diabetic nephropathy were more frequent in Cagliari (higher age and diabetes prevalence), and interstitial diseases in Le Mans. In the multivariate logistic regression, CKD diagnosis was associated with preterm delivery (adjusted P = 0.035). Gestation was 1 week shorter in patients diagnosed with CKD (Kaplan-Meier P = 0.007). In Cox analysis, CKD remained associated with shorter gestation after adjustment for age and parity.
CONCLUSIONS
The prevalence of newly diagnosed CKD is high after PE (19% versus expected 3% in women of childbearing age), supporting a systematic nephrology work-up after PE.
Identifiants
pubmed: 34338783
pii: 6335680
doi: 10.1093/ndt/gfab225
pmc: PMC9317168
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1488-1498Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of ERA.
Déclaration de conflit d'intérêts
No conflict of interest is reported by any of the authors. The results presented in this article have not been published previously in whole or part, except in abstract format.
Références
J Am Soc Nephrol. 2015 Aug;26(8):2011-22
pubmed: 25766536
Ultrasound Obstet Gynecol. 2017 Apr;49(4):478-486
pubmed: 27804212
PLoS One. 2019 Oct 17;14(10):e0223888
pubmed: 31622409
PLoS One. 2012;7(3):e32487
pubmed: 22396771
Nat Rev Nephrol. 2017 Feb;13(2):104-114
pubmed: 27941934
BMJ. 2005 Mar 12;330(7491):565
pubmed: 15743856
BMJ. 2008 Jan 26;336(7637):211-5
pubmed: 18219043
BMJ. 2016 Apr 19;353:i1753
pubmed: 27094586
Matern Child Health J. 2016 Nov;20(Suppl 1):22-27
pubmed: 27562797
Kidney Int Rep. 2019 Mar 26;4(6):842-853
pubmed: 31194119
Int J Gynaecol Obstet. 2019 May;145 Suppl 1:1-33
pubmed: 31111484
Clin J Am Soc Nephrol. 2016 Jun 6;11(6):1102-13
pubmed: 27094609
J Am Soc Nephrol. 2006 Mar;17(3):837-45
pubmed: 16421228
Kidney Int. 2006 Nov;70(10):1818-22
pubmed: 17003812
JAMA. 2007 Nov 7;298(17):2038-47
pubmed: 17986697
Kidney Int. 2006 Aug;70(4):800-6
pubmed: 16820784
J Nephrol. 2018 Dec;31(6):833-846
pubmed: 30066252
Kidney Int Rep. 2018 Oct 25;4(1):159-162
pubmed: 30596179
J Nephrol. 2019 Dec;32(6):977-987
pubmed: 31317437
Kidney Int. 2013 Jan;83(1):177-81
pubmed: 23014459
J Clin Med. 2018 Aug 11;7(8):
pubmed: 30103519
J Clin Med. 2018 Nov 05;7(11):
pubmed: 30400594
Am J Kidney Dis. 2017 Apr;69(4):498-505
pubmed: 27707553
Kidney Int. 2019 Sep;96(3):711-727
pubmed: 31352975
PLoS One. 2016 Jul 06;11(7):e0158765
pubmed: 27383068
J Nephrol. 2017 Jun;30(3):307-317
pubmed: 28434090
Obstet Gynecol. 2020 Jun;135(6):e237-e260
pubmed: 32443079
Lancet. 2020 Feb 29;395(10225):709-733
pubmed: 32061315
Clin J Am Soc Nephrol. 2020 Sep 7;15(9):1371-1380
pubmed: 32241779
Am J Kidney Dis. 2010 Jun;55(6):1026-39
pubmed: 20346562
Acta Diabetol. 2017 Jan;54(1):9-17
pubmed: 27639869
J Am Soc Nephrol. 2014 Jul;25(7):1533-44
pubmed: 24511125
Ther Adv Cardiovasc Dis. 2008 Aug;2(4):249-59
pubmed: 19124425
J Womens Health (Larchmt). 2019 Sep;28(9):1246-1253
pubmed: 31259648
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577